1. Academic Validation
  2. Identification of the Fanconi anemia complementation group I gene, FANCI

Identification of the Fanconi anemia complementation group I gene, FANCI

  • Cell Oncol. 2007;29(3):211-8. doi: 10.1155/2007/151968.
Josephine C Dorsman 1 Marieke Levitus Davy Rockx Martin A Rooimans Anneke B Oostra Anneke Haitjema Sietske T Bakker Jûrgen Steltenpool Dezsö Schuler Sheila Mohan Detlev Schindler Fré Arwert Gerard Pals Christopher G Mathew Quinten Waisfisz Johan P de Winter Hans Joenje
Affiliations

Affiliation

  • 1 Department of Clinical Genetics, Vrije Universiteit Medical Center, Van der Boechorststraat 7, NL-1081 BT Amsterdam, The Netherlands.
Abstract

To identify the gene underlying Fanconi anemia (FA) complementation group I we studied informative FA-I families by a genome-wide linkage analysis, which resulted in 4 candidate regions together encompassing 351 genes. Candidates were selected via bioinformatics and data mining on the basis of their resemblance to other FA genes/proteins acting in the FA pathway, such as: degree of evolutionary conservation, presence of nuclear localization signals and pattern of tissue-dependent expression. We found a candidate, KIAA1794 on chromosome 15q25-26, to be mutated in 8 affected individuals previously assigned to complementation group I. Western blots of endogenous FANCI indicated that functionally active KIAA1794 protein is lacking in FA-I individuals. Knock-down of KIAA1794 expression by siRNA in HeLa cells caused excessive chromosomal breakage induced by mitomycin C, a hallmark of FA cells. Furthermore, phenotypic reversion of a patient-derived cell line was associated with a secondary genetic alteration at the KIAA1794 locus. These data add up to two conclusions. First, KIAA1794 is a FA gene. Second, this gene is identical to FANCI, since the patient cell lines found mutated in this study included the reference cell line for group I, EUFA592.

Figures